VTIAF
Price:
$5.99
Market Cap:
$69.03M
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
Industry
Medical - Care Facilities
IPO Date
2020-02-18
Stock Exchange
PNK
Ticker
VTIAF
According to VITA 34 AG’s latest financial reports and current stock price. The company's current ROE is 10.96%. This represents a change of 311.53% compared to the average of 2.66% of the last 4 quarters.
The mean historical ROE of VITA 34 AG over the last ten years is -15.68%. The current 10.96% ROE has changed -169.90% with respect to the historical average. Over the past ten years (40 quarters), VTIAF's ROE was at its highest in in the December 2023 quarter at 15.65%. The ROE was at its lowest in in the December 2022 quarter at -117.13%.
Average
-15.68%
Median
2.27%
Minimum
-165.98%
Maximum
8.36%
Discovering the peaks and valleys of VITA 34 AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.72%
Maximum Annual ROE = 8.36%
Minimum Annual Increase = -358.03%
Minimum Annual ROE = -165.98%
Year | ROE | Change |
---|---|---|
2023 | -7.92% | -95.23% |
2022 | -165.98% | 1.72% |
2021 | -9.11% | -285.90% |
2020 | 4.90% | 9.52% |
2019 | 4.48% | 59.10% |
2018 | 2.81% | -358.03% |
2017 | -1.09% | -163.21% |
2016 | 1.73% | -79.36% |
2015 | 8.36% | 67.73% |
2014 | 4.98% | 25.45% |
The current ROE of VITA 34 AG (VTIAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-61.00%
5-year avg
-34.73%
10-year avg
-15.68%
VITA 34 AG’s ROE is less than Universal Health Services, Inc. (17.92%), less than Tenet Healthcare Corporation (42.68%), less than DaVita Inc. (181.22%), greater than AMN Healthcare Services, Inc. (-17.66%), less than Acadia Healthcare Company, Inc. (8.57%),
Company | ROE | Market cap |
---|---|---|
17.92% | $11.41B | |
42.68% | $13.16B | |
181.22% | $10.79B | |
-17.66% | $769.55M | |
8.57% | $2.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VITA 34 AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VITA 34 AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is VITA 34 AG's ROE?
How is the ROE calculated for VITA 34 AG (VTIAF)?
What is the highest ROE for VITA 34 AG (VTIAF)?
What is the 3-year average ROE for VITA 34 AG (VTIAF)?
What is the 5-year average ROE for VITA 34 AG (VTIAF)?
How does the current ROE for VITA 34 AG (VTIAF) compare to its historical average?